A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia
COVID-19 had a mild clinical course in patients with Agammaglobulinemia lacking B lymphocytes,
whereas it developed aggressively in Common Variable Immune Deficiency. Our data offer mechanisms for
possible therapeutic targets.